½ÃÀ庸°í¼­
»óǰÄÚµå
1608998

¼¼°èÀÇ ÀÇ·á±â±â ºÐ¼®½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå : ¼­ºñ½ºº°, Ä¡·á ºÐ¾ßº°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Medical Device Analytical Testing Outsourcing Market by Services (Bioburden Testing, Extractable & Leachable, Material Characterization), Therapeutic Areas (Cardiology, Dental, Diabetes Care), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 197 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÇ·á±â±â ºÐ¼®½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀåÀº 2023³â¿¡ 720¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 771¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.79%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 1,218¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÇ·á±â±â ºÐ¼®½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀåÀº ÀÇ·á±â±âÀÇ ÄÄÇöóÀÌ¾ð½º¿Í È¿À²¼ºÀ» º¸ÀåÇϱâ À§ÇØ Á¦3ÀÚ ½ÃÇè¼Ò¿¡¼­ Á¦°øÇÏ´Â Àç·á Ư¼ºÈ­, Á¦Ç° °ËÁõ, ¾ÈÀü¼º ½ÃÇè µî ´Ù¾çÇÑ ¼­ºñ½º¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ¾Æ ¿ìÆ®¼Ò½ÌÀÇ Çʿ伺Àº ÀÇ·á±â±âÀÇ º¹ÀâÈ­, ±ÔÁ¦±âÁØÀÇ ¾ö°ÝÈ­, ¸¹Àº Á¦Á¶¾÷ü°¡ »ç³»¿¡¼­ ÀÌ¿ëÇÒ ¼ö ¾ø´Â Àü¹®Áö½ÄÀÇ Çʿ伺À¸·ÎºÎÅÍ »ý°Ü³ª°í ÀÖ½À´Ï´Ù. ±â±â, ¼ö¼ú ±â±¸ µî ´Ù¾çÇÑ Àåºñ¿¡ Àû¿ëµÇ¸ç ÁÖ·Î º´¿ø, Ŭ¸®´Ð, ¿¬±¸ ±â°ü µîÀÇ ÃÖÁ¾ »ç¿ëÀÚ¿¡°Ô ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ¼¼°èÈ­ µîÀ» µé ¼ö ÀÖÀ¸¸ç, ½ÃÇè ¼­ºñ½ºÀÇ ¾Æ¿ô¼Ò½Ì ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦Ç°ÀÇ ºñ¿ë È¿À²¼º°ú ½ÃÀå Ãâ½Ã±îÁöÀÇ ½Ã°£ ´ÜÃàÀÇ ÃßÁøÀº ÄÄÇöóÀÌ¾ð½º¿Í ½ÃÇè¿¡ ƯȭµÈ ±â¾÷¿¡ ºñÁî´Ï½º ±âȸ¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. Èï½ÃÀåÀº È®´ëÀÇ Å« °¡´É¼ºÀ» Áö´Ï°í ÀÖ½À´Ï´Ù. ±×·¯³ª °íµµÀÇ °Ë»ç ±â¼ú¿¡ µû¸¥ °íºñ¿ë, ¼öºñ Àǹ«¿¡ ´ëÇÑ ¿ì·Á, Áö¿ª¿¡ ÀÇÇÑ ±ÔÁ¦ ¿ä°ÇÀÇ ÆíÂ÷ µîÀÇ °úÁ¦°¡ ½ÃÀåÀÇ ÁøÀüÀ» ¹æÇØÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °úÁ¦¸¦ ±Øº¹ÇÏ°í ¼ºÀåÀ» ±Ø´ëÈ­Çϱâ À§ÇØ ±â¾÷Àº °Ë»ç ÀýÂ÷ ÀÚµ¿È­ ¹× µðÁöÅÐ ÅëÇÕ°ú °°Àº ºÐ¾ß¿¡¼­ ±â¼ú Çõ½ÅÀ» ÃßÁøÇϰí, ¿¹Ãø ÀλçÀÌÆ®À» À§ÇÑ µ¥ÀÌÅÍ ºÐ¼®À» °­È­Çϰí, ¼¼°è ¹èÆ÷¸¦ À§ÇÑ Àü·«Àû ÆÄÆ®³Ê½Ê ±¸Ãà¿¡ ÁÖ·ÂÇØ¾ßÇÕ´Ï´Ù. ÀûÇÕ¼º°ú ¹Ì»ý¹°Çаú °°Àº Àü¹®ÀûÀÎ °Ë»ç ´É·Â °³¹ß¿¡ ÅõÀÚÇÔÀ¸·Î½á °æÀï ¿ìÀ§¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. µÞ¹ÞħµÇ±â ¶§¹®¿¡ °æÀï·Â À¯Áö À̸¦ À§Çؼ­´Â ÀÌÇØ°ü°èÀÚÀÇ ¹Îø¼º°ú Çõ½ÅÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÃÖ÷´Ü ±â¼ú¿¡ ÅõÀÚÇØ¾ßÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 720¾ï 8,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 771¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 1,218¾ï 7,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 7.79%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀÇ·á±â±â ºÐ¼®½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. °áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°Í Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àúħ½À ¼ö¼úÀÇ º¸±Þ·ü Áõ°¡
    • ǰÁú ±âÁØ Áؼö Áõ°¡¿Í ½ÃÀå ÅõÀÔ ºñ¿ë Àý°¨
    • ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ±â¾÷¿¡ ÀÇÇÑ ºê·£µå º¸È£¿¡ÀÇ ÁÖ·ÂÀÇ Çâ»ó
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¿¹Ãø ºÐ¼®ÀÇ ½Ç½Ã¿¡ µû¸¥ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • ½ÅÈï±¹ÀÇ ÇコÄÉ¾î ºÎ¹®¿¡¼­ÀÇ ¼ö¿ä Áõ°¡
    • ´Ù¾çÇÑ ÀÇ·á±â±â¿¡¼­ AI¿Í IoTÀÇ ¹ßÀü
  • ½ÃÀåÀÇ °úÁ¦
    • ¹ýÀû, ±ÔÁ¦Àû ¹®Á¦ÀÇ Á¸Àç

Porter's Five Forces : ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ À־ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ¹× ±ÇÀå ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ ¹æ¹ýÀ» »ç¿ëÇÏ¸é °æÀï ±¸µµ¿¡¼­ ¾î·Á¿òÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • Àúħ½À ¼ö¼úÀÇ º¸±Þ·ü Áõ°¡
      • ǰÁú ±âÁØ Áؼö °­È­ ¹× ½ÃÀå ÅõÀÔ ºñ¿ë Àý°¨
      • ÀÇ·á±â±â ºÐ¼® Å×½ºÆ® ¾Æ¿ô¼Ò½Ì ȸ»ç°¡ ºê·£µå º¸È£¿¡ Á¡Á¡ ÁßÁ¡À» µÎ°í
    • ¾ïÁ¦¿äÀÎ
      • ¿¹Ãø ºÐ¼®ÀÇ ±¸Çö¿¡ µû¸¥ °íºñ¿ë
    • ±âȸ
      • ½ÅÈï±¹ÀÇ ÇコÄÉ¾î ºÐ¾ß·ÎºÎÅÍ ¼ö¿ä Áõ°¡
      • °¢Á¾ ÀÇ·á±â±â¿¡ À־ÀÇ AI?IoTÀÇ ¹ßÀü
    • °úÁ¦
      • ¹ýÀû ¹× ±ÔÁ¦»óÀÇ ¹®Á¦ÀÇ Á¸Àç
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå : ¼­ºñ½ºº°

  • ¹ÙÀÌ¿À¹Ùµ§ ½ÃÇè
  • ÃßÃâ °¡´É ¹× ħÃâ °¡´É
  • Àç·á Ư¼º Æò°¡
  • ¹°¸® Å×½ºÆ®
  • ¹«±Õ½ÃÇè

Á¦7Àå ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå : Ä¡·á ¿µ¿ªº°

  • ½ÉÀ庴ÇÐ
  • Ä¡°ú
  • ´ç´¢º´ °ü¸®
  • Áø´Ü À̹ÌÁö
  • ¾à¹°Àü´Þ
  • ³»½Ã°æ °Ë»ç
  • ÀϹݿܰú ¹× ¼ºÇü¿Ü°ú
  • ü¿Ü Áø´Ü
  • ¾È°ú
  • Á¤Çü¿Ü°ú

Á¦8Àå ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ASCs
  • º´¿ø
    • ¼Ò¸ðǰ
    • ÀåÄ¡

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á±â±â ºÐ¼®½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á±â±â ºÐ¼® ½ÃÇè ¾Æ¿ô¼Ò½Ì ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Charles River Laboratories International, Inc.
  • EAG Laboratories
  • Eurofins Scientific SE
  • Intertek Group PLC
  • North American Science Associates, Inc.
  • SGS SA
  • The Smithers Group Inc.
  • Wuxi Apptec
BJH 24.12.19

The Medical Device Analytical Testing Outsourcing Market was valued at USD 72.08 billion in 2023, expected to reach USD 77.14 billion in 2024, and is projected to grow at a CAGR of 7.79%, to USD 121.87 billion by 2030.

The medical device analytical testing outsourcing market encompasses a range of services including material characterization, product validation, and safety testing, offered by third-party laboratories to ensure the compliance and efficacy of medical devices. The necessity for outsourcing arises from the increasing complexity of medical devices, stringent regulatory standards, and a need for specialized expertise that may not be available in-house for many manufacturers. Applications span from preclinical trials to post-market surveillance across various devices such as consumables, diagnostics equipment, and surgical instruments, primarily serving end-users like hospitals, clinics, and research institutes. Growth factors include escalating chronic diseases, technological advancements in medical devices, and globalization of quality assurance standards, driving demand for outsourced testing services. Additionally, the push for cost-efficiency and faster time-to-market for products presents opportunities for specialized compliance and testing firms. Emerging markets, with growing healthcare infrastructures, offer significant potential for expansion. However, challenges such as high costs associated with advanced testing techniques, confidentiality concerns, and variability in regulatory requirements across regions can hinder market progress. To overcome these challenges and maximize growth, companies should innovate in areas such as automation and digital integration of testing procedures, enhance data analytics for predictive insights, and focus on building strategic partnerships for global reach. Additionally, investing in the development of specialized testing capabilities, such as biocompatibility and microbiology, could provide competitive advantage. The market is inherently dynamic, driven by continuous technological evolution and regulatory changes, necessitating agility and innovation from stakeholders to remain competitive. Companies in this sector should continually monitor regulatory landscapes and invest in cutting-edge technologies to capture emerging opportunities and address ongoing market needs effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 72.08 billion
Estimated Year [2024] USD 77.14 billion
Forecast Year [2030] USD 121.87 billion
CAGR (%) 7.79%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Device Analytical Testing Outsourcing Market

The Medical Device Analytical Testing Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence rate of minimally invasive surgeries
    • Growing adherence to quality standards and reduction in cost to market
    • Increasing focus of medical device analytics testing outsourcing companies on brand protection
  • Market Restraints
    • High cost associated with the implementation of predictive analysis
  • Market Opportunities
    • Increasing demand from healthcare sectors in emerging countries
    • Development in AI and IoT in various medical devices
  • Market Challenges
    • Presence of legal and regulatory issues

Porter's Five Forces: A Strategic Tool for Navigating the Medical Device Analytical Testing Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Device Analytical Testing Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Device Analytical Testing Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Device Analytical Testing Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Device Analytical Testing Outsourcing Market

A detailed market share analysis in the Medical Device Analytical Testing Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Device Analytical Testing Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Device Analytical Testing Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Device Analytical Testing Outsourcing Market

A strategic analysis of the Medical Device Analytical Testing Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Device Analytical Testing Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Charles River Laboratories International, Inc., EAG Laboratories, Eurofins Scientific SE, Intertek Group PLC, North American Science Associates, Inc., SGS SA, The Smithers Group Inc., and Wuxi Apptec.

Market Segmentation & Coverage

This research report categorizes the Medical Device Analytical Testing Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Bioburden Testing, Extractable & Leachable, Material Characterization, Physical Testing, and Sterility Testing.
  • Based on Therapeutic Areas, market is studied across Cardiology, Dental, Diabetes Care, Diagnostic Imaging, Drug Delivery, Endoscopy, General & Plastic Surgery, IVD, Ophthalmic, and Orthopedic.
  • Based on End-User, market is studied across ASCs and Hospital. The Hospital is further studied across Consumables and Equipment.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence rate of minimally invasive surgeries
      • 5.1.1.2. Growing adherence to quality standards and reduction in cost to market
      • 5.1.1.3. Increasing focus of medical device analytics testing outsourcing companies on brand protection
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the implementation of predictive analysis
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand from healthcare sectors in emerging countries
      • 5.1.3.2. Development in AI and IoT in various medical devices
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of legal and regulatory issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Device Analytical Testing Outsourcing Market, by Services

  • 6.1. Introduction
  • 6.2. Bioburden Testing
  • 6.3. Extractable & Leachable
  • 6.4. Material Characterization
  • 6.5. Physical Testing
  • 6.6. Sterility Testing

7. Medical Device Analytical Testing Outsourcing Market, by Therapeutic Areas

  • 7.1. Introduction
  • 7.2. Cardiology
  • 7.3. Dental
  • 7.4. Diabetes Care
  • 7.5. Diagnostic Imaging
  • 7.6. Drug Delivery
  • 7.7. Endoscopy
  • 7.8. General & Plastic Surgery
  • 7.9. IVD
  • 7.10. Ophthalmic
  • 7.11. Orthopedic

8. Medical Device Analytical Testing Outsourcing Market, by End-User

  • 8.1. Introduction
  • 8.2. ASCs
  • 8.3. Hospital
    • 8.3.1. Consumables
    • 8.3.2. Equipment

9. Americas Medical Device Analytical Testing Outsourcing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Medical Device Analytical Testing Outsourcing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Medical Device Analytical Testing Outsourcing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Charles River Laboratories International, Inc.
  • 2. EAG Laboratories
  • 3. Eurofins Scientific SE
  • 4. Intertek Group PLC
  • 5. North American Science Associates, Inc.
  • 6. SGS SA
  • 7. The Smithers Group Inc.
  • 8. Wuxi Apptec
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦